skip to content
 
  • K Liddell, 'Human Bodies in Medicine and Research: Regulatory frameworks and their impact: a comparative report on the literature'. A Report for the Nuffield Council on Bioethics for use in its report on Human Bodies in Medicine and Research (working paper, 2011)
  • K Liddell, 'The Health Impact Fund: A Critique' in T Pogge, M Rimmer, K Rubenstein Incentives for Global Health (Cambridge University Press 2010)
  • S Gaisser, M Hopkins, K Liddell, E Zika, D Ibarreta, 'The phantom menace of gene patents' (2009) 458 (7237) Nature 407-9
  • K Liddell, 'Beyond a Rebarbative Commitment to Consent' in J McMillan, O Corrigan, K Liddell, M Richards, C Weijer (eds), The Limits of Consent (Oxford University Press 2009)
  • K Liddell and M Richards, 'Consent and Beyond: Some Conclusions' in J McMillan, O Corrigan, K Liddell, M Richards, C Weijer (eds), The Limits of Consent (Oxford University Press 2009)
  • J McMillan, O Corrigan, K Liddell, M Richards, C Weijer (eds), The Limits of Consent (Oxford University Press 2009)
  • E Jones and K Liddell, 'Should healthy volunteers in clinical trials be paid according to risk? Yes.' (2009) 339:b4142 British Medical Journal
  • K Liddell, S Hogarth, D Melzer, R Zimmern, 'Patents as Incentives for Translational and Evaluative Research: the case of genetic tests and their improved clinical performance' (2008) 3 Intellectual Property Quarterly 286-327
  • K Liddell, 'Patent entitlement claims: Markem overruled' (2008) 67 (2) Cambridge Law Journal 256-60
  • D Melzer, S Hogarth, K Liddell, T Ling, S Sanderson, R L Zimmern, 'Genetic tests for common diseases: new insights, old concerns' (2008) 336 (7644) British Medical Journal 590-3
  • S Hogarth, K Liddell, T Ling, S Sanderson, R Zimmern, D Melzer, 'Closing the gaps - enhancing the regulation of genetic tests using responsive regulation' (2007) 62(4) Food and Drug Law Journal 831-48
  • K Liddell, J Bion, D Chamberlain, C Druml, E Kompanje, F Lemaire, D Menon, B Vhrovac, C Wiederman, 'Medical Research Involving Incapacitated Adults: Implications of the EU Clinical Trials Directive 2001/20/EC' (2006) 14 Medical Law Review 367-417
  • K Liddell 'Legal and Governance Framework', prepared for Academy of Medical Sciences, Personal Data for Public Good: Using Health Information in Medical Research' (AMS London 2006) pp 21-43
  • S Hogarth, K Liddell, T Ling, D Melzer, S Sanderson, R Zimmern, Regulating Pharmacogenomics: An overview of developments in various countries and industry response to regulatory initiatives: A report for Health Canada (Health Canada Ottawa 2006)
  • K Liddell, Briefing paper on Personal Data in Medical Research circulated to participants at AMS/PHGU/Law Symposium
  • A Iversen, K Liddell, N Fear, M Hotopf, S Wessely, ‘Consent, Confidentiality and the Data Protection Act’ (2006) 332 BMJ 165
  • Genetic Interest Group, ‘Human Rights, Privacy and Medical Research: Analysing UK Policy on Tissue and Data’ (2006). K Liddell acted as Legal Adviser and contributed to the text.
  • K Liddell, D Chamberlain, et al, ‘The European Clinical Trials Directive Revisited: The VISEAR Recommendations’ (2006) 69(1) Resuscitation 9-14
  • K Liddell et al, ‘European Clinical Trials and Research Involving Incapacitated Adults’ (2006) Wien Klinische Wochenschrift 183-191 (The Middle European Journal of Medicine)
  • K Liddell and A Hall, ‘Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue’ (2005) 13(2) Medical Law Review  
  •  ‘The Mythical Connection Between Data Protection Law and Confidentiality: Processing Data “Lawfully” ’ (2005) 6(6) Bio-science Law Review 215
  • Oonagh Corrigan, Kathleen Liddell, John McMillan, Alison Stewart and Susan Wallace, ‘Ethical, Legal and Social Issues in Stem Cell Research and Therapy’ (CGKP, March 2005). 7
  • ‘Emerging Regulatory Issues for Human Stem Cell Medicine’ (2005) 1(1) Genomics, Society and Policy 54. (with S Wallace)
  • ‘Legislation and Research in Intensive Care and Emergency Medicine’ (2004) Journal of the Intensive Care Society 98. (with D K Menon) 
  •  ‘The Human Tissue Bill and the Mental Capacity Bill’ (2004) 328 British Medical Journal 1510. (with D K Menon and R Zimmern)
  •  ‘Just Genetic Discrimination? The Ethics of Australian Law Reform Proposals’ (2002) 25(2) University of New South Wales Law Journal 160
  •  ‘Did the Watchdog Bark, Bite or Whimper?– The UK Report on the Use of Personal Genetic Information’ (2002) 9(3) European Journal of Health Law 243
  •  ‘Litigation: Effects on Medical Research’ in N. J. Smelser and Paul B. Baltes (eds) International Encyclopedia of the Social & Behavioural Sciences (Pergamon Oxford 2001) p 8995-8999
  •  ‘Biolaw and Deliberative Democracy: Regulating Human Genetic Technology in a Morally Pluralist Society’ (D.Phil thesis, Faculty of Law, University of Oxford, 2003)
  • ‘Biolaw’ in M. McDonald, ‘Languages of Accountability for Biotechnology’ (Berghahn, Oxford, 2006)
  • Forthcoming: ‘Human Genetics, Bioethics and Intellectual Property’ (Cambridge University Press, Cambridge, 2006) (With WR Cornish, M Llewelyn and M Adcock)
  • Book review: Graeme Laurie, Genetic Privacy: A Challenge to Medico-Legal Norms' Cambridge: Cambridge University Press, 2002 (2004) Edinburgh Law Review
  • Book review: Rosemary Pattenden, The Law of Professional–Client Confidentiality: Regulating the Disclosure of Confidential Personal Information. Oxford: Oxford University Press, 2003’ (2004) Bio-science Law Review
  • Book review: Graeme Laurie, Genetic Privacy: A Challenge to Medico-Legal Norms' Cambridge: Cambridge University Press, 2002 (2004) Edinburgh Law Review
  • Book review: Rosemary Pattenden, The Law of Professional–Client Confidentiality: Regulating the Disclosure of Confidential Personal Information. Oxford: Oxford University Press, 2003’ (2004) Bio-science Law Review
  • Case note: Purposive Interpretation and the March of Genetic Technology. A comment on R (Quintavalle) v Human Fertilisation and Embryology Authority (cell nuclear replacement) [2003] 2 W.L.R. 692 [2003] 62 Cambridge Law Journal 563